Advances in Therapy

, Volume 19, Issue 2, pp 101–107 | Cite as

Effect of cod liver oil on symptoms of rheumatoid arthritis

  • Joerg Gruenwald
  • Hans Joachim Graubaum
  • Andrea Harde


In this pilot study, 43 patients with rheumatoid arthritis ingested 1 g of cod liver oil (one capsule) daily for 3 months. Decreases occurred in morning stiffness (52.4%;P < 10-3), painful (42.7%) and swollen (40%) joints (P= 10−3 each), and pain intensity (67.5%). Ratings of “good” or “very good” were awarded by 68% of the patients for efficacy and by 95% for tolerability. Eleven patients reported nonsevere adverse effects that in 3 cases may have been related to the study preparation. Cod liver oil can be recommended for the treatment of rheumatoid arthritis.


cod liver oil fish oil rheumatoid arthritis rheumatic symptoms rheumatalgia antirheumatic therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum. 1988;31:315–324.PubMedCrossRefGoogle Scholar
  2. 2.
    Schäfler A, Braun J, Renz U.Klinikleitfaden. Schwerpunkt Innere Medizin. Stuttgart: Jungjohann Verlagsgesellschaft; 1993:462.Google Scholar
  3. 3.
    Sanders TAB. Marine oils: metabolic effects and role in human nutrition.Proc Nutr Soc. 1993; 52:457–472.PubMedCrossRefGoogle Scholar
  4. 4.
    Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Catersor B. Ω3 Fatty acids specifically modulate catabolic factors involved in articular cartilage degradation.J Biol Chem. 2000; 275:721–724.PubMedCrossRefGoogle Scholar
  5. 5.
    Kremer JM, Jubiz W, Michalek A, et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis.Ann Intern Med. 1987;106:497–503.PubMedGoogle Scholar
  6. 6.
    van der Tempel H, Tulleken JE, Limburg PC, Muskiet FA, van Rijswijk MH. Effects of fish oil supplementation in rheumatoid arthritis.Ann Rheum Dis. 1990;49:76–80.PubMedCrossRefGoogle Scholar
  7. 7.
    Sellmayer A, Hrboticky N, Weber PC. Ω-3-Fettsäuren in der Prävention kardiovaskulärer Erkrankungen.Ernährungs-Umschau. 1996;43:122–128.Google Scholar
  8. 8.
    Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3-fatty acid supplementation in active rheumatoid arthritis.Arthritis Rheum. 1994;37:824–829.PubMedCrossRefGoogle Scholar
  9. 9.
    Lau CS, Morley KD, Belch JJF. Effects of fish oil supplementation on non-steroidal antiinflammatory drug requirement in patients with mild rheumatoid arthritis-a double-blind placebo controlled study.Br J Rheumatol. 1993;32:982–989.PubMedCrossRefGoogle Scholar
  10. 10.
    Endres S, de Caterina R, Schmidt EB, Kristensen SD. Ω-3 Polyunsaturated fatty acids: update 1995.EurJClin Invest. 1995;25:629–638.Google Scholar
  11. 11.
    Kremer JM. Omega-3 fatty acid supplements in rheumatoid arthritis.ISSFAL Newslett. 1997; 4:5–8.Google Scholar
  12. 12.
    Nielsen GL, Faarvang KL, Thomsen BS, et al. The effects of dietary supplements with Ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial.EurJClin Invest. 1992;22:687–691.Google Scholar
  13. 13.
    Felson DT, Anderson JJ, Meenan RF. Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials.Arthritis Rheum. 1990;33:140–149.PubMedCrossRefGoogle Scholar
  14. 14.
    Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials.Arthritis Rheum. 1993;36:729–739.PubMedCrossRefGoogle Scholar

Copyright information

© Health Communications Inc 2002

Authors and Affiliations

  • Joerg Gruenwald
    • 1
  • Hans Joachim Graubaum
    • 1
  • Andrea Harde
    • 1
  1. 1.Institute for PhytopharmaceuticalsPhytoPharm ConsultingBerlinGermany

Personalised recommendations